🔎 Trials Near Me

Home › Atherosclerosis › Texas › Amarillo

Atherosclerosis clinical trials in Amarillo, TX

6 studies for Atherosclerosis are looking for participants at sites in and around Amarillo (within about 30 miles). Open a study to see who can join and how to contact the study team.

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)

RecruitingPhase 3
  • PharmaTex Research, Amarillo
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07157774

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • PharmaTex Research, LLC, Amarillo
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

RecruitingPhase 2
  • PharmaTex Research, LLC, Amarillo
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RecruitingPhase 3
  • Research Site, Amarillo
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

RecruitingPhase 3
  • PharmaTex Research LLC, Amarillo
Ages 18 to 80 · All sexes · Updated Aug 7, 2026 · NCT06813911

Pelacarsen Roll-over Extension Program

RecruitingPhase 3
  • Pharma Tex Research, Amarillo
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973

About Atherosclerosis

Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.

More about Atherosclerosis on MedlinePlus

Atherosclerosis trials in other cities

Other studies in Amarillo

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.